What Are Some Challenges in Targeting Actin in Cancer?
One of the main challenges is the toxicity associated with targeting actin, as it is essential for many normal cellular processes. Additionally, cancer cells often develop resistance to therapies targeting the cytoskeleton. Therefore, understanding the specific alterations in actin dynamics in cancer cells is crucial to developing effective treatments with minimal side effects.
